Verily Life Sciences, a healthcare unit of Alphabet said founder and Chief Executive Officer Andy Conrad would be replaced in the top role, as the company attempts to find commercial uses for its wide-ranging project portfolio.
Stephen Gillett, the current president of Verily, will succeed Mr. Conrad as CEO in January next year, with Mr. Conrad becoming executive chairman. Alphabet led a $1 billion round of new funding in the company with other investors, Verily said Friday in a statement announcing the leadership changes.
